Full Text View
Tabular View
No Study Results Posted
Related Studies
Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women
This study has been withdrawn prior to enrollment.
( Sponsor has withdrawn support for this study and it will not be performed )
Study NCT00682721   Information provided by University of Pittsburgh

First Received on May 16, 2008.   Last Updated on February 29, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Vaginosis
Herpes Simplex Virus Type II
Additional conditions recognized in this trial
Herpes Simplex
Vaginosis, Bacterial
More general conditions related to this trial
Bacterial Infections
DNA Virus Infections
Genital Diseases, Female
Herpesviridae Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Viral
Vaginal Diseases
Vaginitis
Virus Diseases
Interventions listed in this trial
Placebo
Valacyclovir
Additional drug interventions recognized in this trial
Acyclovir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Pittsburgh


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services